We provide senior-led expertise in early-phase clinical development, helping biotech, academic sponsors, and CRO partners execute studies with controlled risk and predictable delivery. Our focus is on First-in-Human, proof-of-concept, and other complex early clinical programs across global regions. We cover Clinical Operations, Clinical Development, Biometrics (Data Management & Biostatistics), Pharmacovigilance/Drug Safety, Regulatory Affairs, and outsourced DPO & Privacy Advisory—delivering integrated support across the full early-phase lifecycle. Our teams have delivered numerous Phase I and II studies, including first-in-human and proof-of-concept programs, bringing hands-on experience in complex protocols, site execution, and cross-functional delivery. We operate across Europe, North America, APAC, and LATAM. For enquiries, partnerships, or project discussions, please contact us directly at contact@inventioscience.com
| Employees | 1 (1 on RocketReach) |
| Industry | Research Services |
Looking for a particular Inventio Science employee's phone or email?
Kala-Kala is the Founder and CEO of Inventio Science.
1 people are employed at Inventio Science.
Inventio Science is based in London, England.